Unfortunately, data assessing placental manifestations in SRD is scarce and there are no studies that explore placental lesions in depth, for example concerning interferon (IFN) or changes in immune cells count, and their association with APO in different groups of SRD patients. This evidence concerns the gene IFNA1 and dopa-responsive dystonia due to sepiapterin reductase deficiency.